Part­ner­ing with Am­gen vet Sean Harp­er, vet­er­an VC Beth Sei­den­berg un­veils a $320M fund and a unique fo­cus on…wait for it…LA

Beth Sei­den­berg is end­ing a brief qui­et spell this morn­ing, ful­fill­ing ex­pec­ta­tions that she was piec­ing to­geth­er her own biotech ven­ture fund — and adding a few big twists that might take you by sur­prise.

First, Sei­den­berg told me in a pre­view to to­day’s an­nounce­ment, she is launch­ing West­lake Vil­lage BioPart­ners with a new and very high pro­file part­ner: Sean Harp­er, who re­cent­ly stepped down from his perch as Am­gen R&D chief to take a hands-on role as a new­ly re­born ven­ture cap­i­tal­ist. Sec­ond, she plans to play a lead­ing role in turn­ing Los An­ge­les in­to the next sig­nif­i­cant biotech hub to be reck­oned with, and they have $320 mil­lion to help light the fire.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER